Combined modality therapy of esophageal cancer: Changes in the standard of care? - Editorial Journal Article

  

Authors:	Shah, M. A.; Kelsen, D. P.
Article Title:	Combined modality therapy of esophageal cancer: Changes in the standard of care? - Editorial
Keywords:	cancer chemotherapy; cancer survival; treatment outcome; cancer surgery; survival rate; clinical trial; mortality; bevacizumab; cisplatin; fluorouracil; multimodality cancer therapy; note; cancer radiotherapy; combined modality therapy; cancer staging; positron emission tomography; antineoplastic agent; neoplasm staging; evidence based medicine; evidence-based medicine; computer assisted tomography; antineoplastic combined chemotherapy protocols; editorial; cetuximab; cancer therapy; irinotecan; standard; patient care; esophagus resection; taxane derivative; esophagus cancer; clinical trials; esophagus tumor; esophageal neoplasms; humans; prognosis; human
Journal Title:	Annals of Surgical Oncology
Volume:	11
Issue:	7
ISSN:	1068-9265
Publisher:	Springer
Date Published:	2004-07-01
Start Page:	641
End Page:	643
Language:	English
DOI:	10.1245/aso.2004.04.907
PUBMED:	15197008
PROVIDER:	scopus
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-16644373354&partnerID=40&md5=ecc6f137a6df3c61f65c8d7bef62e7c7
Notes:	Cited By (since 1996):8 -- Export Date: 16 June 2014 -- CODEN: ASONF -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/54914